Consolidated cash flow statements
(unaudited)
|
Nine months ended 30 September |
|
|---|---|---|
(thousands of €) |
2022 |
2021 |
Net loss of the period |
(10,784) |
(119,581) |
|
|
|
Adjustment for non-cash transactions |
(25,707) |
59,050 |
Adjustment for items to disclose separately under operating cash flow |
1,599 |
6,013 |
Adjustment for items to disclose under investing and financing cash flows |
(1,700) |
(28,845) |
Change in working capital other than deferred income |
57,472 |
46,642 |
Cash used for other liabilities related to the acquisition of subsidiaries |
(11,080) |
- |
Decrease in deferred income |
(318,167) |
(295,651) |
|
|
|
Cash used in operations |
(308,367) |
(332,372) |
|
|
|
Interest paid |
(10,940) |
(9,436) |
Interest received |
2,262 |
2,049 |
Corporate taxes paid |
(3,637) |
(297) |
|
|
|
Net cash flows used in operating activities |
(320,682) |
(340,056) |
Purchase of property, plant and equipment |
(19,808) |
(33,907) |
Purchase of and expenditure in intangible fixed assets |
(9,308) |
(1,661) |
Proceeds from disposal of property, plant and equipment |
719 |
- |
Purchase of current financial investments |
(2,505,688) |
(905,124) |
Interest received related to current financial investments |
1,181 |
10 |
Sale of current financial investments |
1,394,549 |
1,901,132 |
Cash in from disposals of subsidiaries, net of cash disposed of |
- |
28,696 |
Cash out from acquisition of subsidiaries, net of cash acquired |
(115,270) |
- |
Cash advances and loans to third parties |
(10,000) |
- |
Proceeds from sale of financial assets held at fair value through profit or loss |
- |
4,045 |
|
|
|
Net cash flows generated from/used in (-) investing activities |
(1,263,625) |
993,191 |
|
|
|
Payment of lease liabilities |
(6,263) |
(5,174) |
Proceeds from capital and share premium increases from exercise of subscription rights |
6,695 |
2,735 |
|
|
|
Net cash flows generated from/used in (-) financing activities |
432 |
(2,438) |
|
|
|
Increase/decrease (-) in cash and cash equivalents |
(1,583,875) |
650,697 |
Cash and cash equivalents at beginning of year |
2,233,368 |
2,143,071 |
|
|
|
Increase/decrease (-) in cash and cash equivalents |
(1,583,875) |
650,697 |
|
|
|
Effect of exchange rate differences on cash and cash equivalents |
26,026 |
40,610 |
|
|
|
Cash and cash equivalents at end of the period |
675,519 |
2,834,378 |
The accompanying notes form an integral part of these condensed consolidated financial statements.
|
30 September |
|
|---|---|---|
(thousands of €) |
2022 |
2021 |
Current financial investments |
3,686,557 |
2,039,787 |
Cash and cash equivalents |
675,519 |
2,834,378 |
Current financial investments and cash and cash equivalents |
4,362,076 |
4,874,165 |
The accompanying notes form an integral part of these condensed consolidated financial statements.